United States / Netherlands / Australia / Denmark / /
Currency
USD / EUR / /
Event
Patent Filing / /
Facility
Merck Unilever Research Arizona State University Leiden University Free University / Cancer Institute Dana-Farber Cancer Institute UMC St. Radboud Roche Institute / Hubrecht Institute / /
IndustryTerm
pharmaceuticals / melanoma therapeutics / cancer therapy / therapy for melanoma / treatment of cancer / therapeutics for cancer / Treatment for melanoma / cancer therapeutics / melanoma therapies / peer / venture capital investors / /
MedicalCondition
cancer / disease / skin cancer / melanoma / heart failure / liver cancer / diseases / neurodegenerative diseases / diverse disease / eye diseases / fibrosis / /
MedicalTreatment
cancer therapeutics / cancer therapy / /
Organization
Kempen & Co Corporate Finance Kreatech Diagnostics Netherlands Cancer Institute Dana-Farber Cancer Institute UMC St. Radboud Roche Institute for Molecular Biology Paula / Hubrecht Institute / Arizona State University / Leiden University / Aglaia Oncology Fund / /
Person
Roel Schaapveld / Mirna Therapeutics / Molecular Biology Paula van Noort / /
Position
CEO / Informal investors CEO / Director R&D Organon/ Schering / /
Breakthrough for treatment of cancer, and other diseases InteRNA Technologies BV is a Utrecht based biotech company that is developing new therapeutics for cancer and other diseases. The approach is based on science deve